Medically reviewed by Renita White, MD Lower levels of estrogen in menopause can make you more vulnerable to osteoporosis.

Estrogen functions through binding of two different estrogen receptors (ESRs), ESR1 and ESR2. Estrogen plays an important role in bone biology, best illustrated by three points of observations ...

Antiresorptive therapies for the treatment of postmenopausal osteoporosis include bisphosphonates, estrogen, selective estrogen receptor modulators and calcitonin, all of which lessen the risk of ...

By incorporating specific types of exercise into a consistent workout routine, you can proactively counter age-related ...

no increased stroke risk was associated with raloxifene use in patients with osteoporosis. Previous studies have hinted at a relationship between the use of raloxifene (a selective estrogen ...

Wark, MBBS, PhD, FRACP Estrogen and 1,25(OH ... the risk of developing osteoporosis increases. In addition, low body mass index, low calcium intake, low level of physical activity, and smoking ...

The second issue is that women go through menopause. Menopause is when your ovaries stop making the larger amounts of estrogen that they were previously making. And when estrogen levels dip ...

Well osteoporosis is more common in women than men and it's particularly an issue after the menopause because when you stop producing estrogen, you will start losing bone. Other risk factors could ...

How the Medications Work: Most of the medications for osteoporosis work by slowing down your bone losses so that your own bone building cells can get caught up and increase your bone density. Estrogen ...

Rising prevalence of osteoporosis among aging populations, lifestyle changes impacting bone health, and ongoing advancements in treatment options. Challenges: High treatment costs and low awareness ...